BRAFV600E mutation in cutaneous lesions of patients with adult Langerhans cell histiocytosis

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 6, 2015-06 ,pp. : 1205-1211

John Wiley & Sons Inc

Access to resources Recommend Favorite

Contiguous verrucous proliferations in syringocystadenoma papilliferum: A retrospective analysis with additional evaluation via mutation‐specific BRAFV600E immunohistochemistry

By  

JOURNAL OF CUTANEOUS PATHOLOGY, Vol. 45, Iss. 3, 2018-03 ,pp. : 212-216

John Wiley & Sons Inc

Access to resources Recommend Favorite

Brief Communications

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 3, 2015-03 ,pp. : 348-351

John Wiley & Sons Inc

Access to resources Recommend Favorite

Generation of a Potential Prognostic Matrix for Papillary Thyroid Cancer that Assesses Age, Tumor Size, Transforming Growth Factor-β, and BRAF^V600E Mutation

By  

Oncology Research and Treatment, Vol. 40, Iss. 10, 2017-09 ,pp. : 586-592

Karger

Access to resources Recommend Favorite

Reply to Preoperative BRAF(V600E) mutation screening is unlikely to alter initial surgical treatment of patients with indeterminate thyroid nodules: A prospective case series of 960 patients

By  

CANCER, Vol. 120, Iss. 7, 2014-04 ,pp. : 1084-1084

John Wiley & Sons Inc

Access to resources Recommend Favorite